<DOC>
	<DOCNO>NCT01340339</DOCNO>
	<brief_summary>The aim study compare efficacy super-LED reverse phototherapy fluorescent reverse phototherapy term late preterm newborn .</brief_summary>
	<brief_title>Reverse Phototherapy With Super Light-emitting Diode ( Super-LED ) Hyperbilirubinemia Term Late Preterm Infants</brief_title>
	<detailed_description>This randomize controlled clinical trial hospitalize infant Professor Fernando Figueira Medicine Institute ( IMIP ) , require phototherapy indication medical team . Following sample calculation , 144 patient randomize accord gestational age ( 350/7-376/7 380/7-416/7 week ) receive super-LED reverse phototherapy fluorescent reverse phototherapy spectral irradiance 8-12 microwatts/cm2/nm.The bilirubin determine micromethod bilirubinometer , blood collection heparinized capillary bilirubin reach level indicates suspension therapy .</detailed_description>
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<mesh_term>Hyperbilirubinemia , Neonatal</mesh_term>
	<criteria>Newborns maternity Professor Fernando Figueira Medicine Institute ( IMIP ) Gestational age 350/7 416/7 week Birth weight great 2200g Absence congenital malformation indication phototherapy 48 hour life Terms consent sign parent guardian Total Bilirubin level indicative phototherapy intensive exchange transfusion RH incompatibility hemolytic disease Mother 's refusal continue participate study Unavailability two type phototherapy equipment randomization Mother newborn receive phenobarbital</criteria>
	<gender>All</gender>
	<minimum_age>35 Weeks</minimum_age>
	<maximum_age>41 Weeks</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Jaundice</keyword>
	<keyword>Hyperbilirubinemia</keyword>
	<keyword>Phototherapy Super-LED Fluorescent lamp</keyword>
</DOC>